Board Meeting11 Nov 2026, 07:32 pm
Pharmaids Pharmaceuticals Ltd Board Approves Unaudited Financial Results
AI Summary
Pharmaids Pharmaceuticals Limited announced that its Board of Directors, in a meeting held on November 11, 2026, has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company also received a Limited Review Report from its statutory auditors, M/s PPKG & Co. The financial results are available on the company's website.
Key Highlights
- Board meeting held on November 11, 2026.
- Unaudited financial results for Q2 FY27 approved.
- Standalone and consolidated results declared.
- Limited Review Report received from auditors.
- Results available on company website.
Price Impact
More from PHARMAID